Chorioamnionitis, respiratory distress syndrome and bronchopulmonary dysplasia in extremely low birth weight infants

Journal of Perinatology

Volumn 31, Issue 3, 2011, Pages 166-170

  Lee, Hyun Ju ^a,b   Kim, Ee Kyung ^a   Kim, Han Suk ^a   Choi, Chang Won ^a,b   Kim, Beyong I I ^a,b   Choi, Jung Hwan ^a  

^a Seoul National University   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

bronchopulmonary dysplasia; chorioamnionitis; preterm; respiratory distress syndrome

Indexed keywords

ARTICLE; CHORIOAMNIONITIS; CONTROLLED STUDY; DISEASE SEVERITY; EXTREMELY LOW BIRTH WEIGHT; FEMALE; GESTATIONAL AGE; HUMAN; INCIDENCE; LUNG DYSPLASIA; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN INTENSIVE CARE; OXYGEN THERAPY; PREDICTION; RETROSPECTIVE STUDY; RISK FACTOR;

BRONCHOPULMONARY DYSPLASIA; CHORIOAMNIONITIS; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 79952314543     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2010.113     Document Type: Article

References (30)

1. Holzman C, Lin X, Senagore P, Chung H. Histologic chorioamnionitis and preterm delivery. Am J Epidemiol 2007; 166: 786-794. (Pubitemid 47428908)
2. Speer CP. Chorioamnionitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia. Neonatology 2009; 95: 353-361.
3. Dempsey E, Chen MF, Kokottis T, Vallerand D, Usher R. Outcome of neonates less than 30 weeks gestation with histologic chorioamnionitis. Am J Perinatol 2005; 22: 155-159. (Pubitemid 40593683)
4. Been JV, Rours IG, Kornelisse RF, Jonkers F, de Krijger RR, Zimmermann LJ. Chorioamnionitis alters the response to surfactant in preterm infants. J Pediatr 2010; 156: 10-15 e1.
5. Choi CW, Kim BI, Hong JS, Kim EK, Kim HS, Choi JH. Bronchopulmonary dysplasia in a rat model induced by intra-amniotic inflammation and postnatal hyperoxia: morphometric aspects. Pediatr Res 2009; 65: 323-327.
6. Jobe AH, Kallapur SG. Chorioamnionitis, surfactant, and lung disease in very low birth weight infants. J Pediatr 2010; 156: 3-4.
7. Verder H, Bohlin K, Kamper J, Lindwall R, Jonsson B. Nasal CPAP and surfactant for treatment of respiratory distress syndrome and prevention of bronchopulmonary dysplasia. Acta Paediatr 2009; 98: 1400-1408.
8. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723-1729. (Pubitemid 32578778)
9. Volpe JJ. Perinatal brain injury: from pathogenesis to neuroprotection. Ment Retard Dev Disabil Res Rev 2001; 7: 56-64. (Pubitemid 32206303)
10. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978; 187: 1-7.
11. Salafia CM, Weigl C, Silberman L. The prevalence and distribution of acute placental inflammation in uncomplicated term pregnancies. Obstet Gynecol 1989; 73: 383-389. (Pubitemid 19063617)
12. Meyer KC, Zimmerman JJ. Inflammation and surfactant. Paediatr Respir Rev 2002; 3: 308-314. (Pubitemid 36546563)
13. Van Marter LJ, Dammann O, Allred EN, Leviton A, Pagano M, Moore M et al. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr 2002; 140: 171-176. (Pubitemid 34183655)
14. Laughon M, Allred EN, Bose C, O'Shea TM, Van Marter LJ, Ehrenkranz RA et al. Patterns of respiratory disease during the first 2 postnatal weeks in extremely premature infants. Pediatrics 2009; 123: 1124-1131.
15. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996; 97: 210-215. (Pubitemid 26049651)
16. Kent A, Dahlstrom JE. Chorioamnionitis/funisitis and the development of bronchopulmonary dysplasia. J Paediatr Child Health 2004; 40: 356-359. (Pubitemid 38938696)
17. Kaukola T, Tuimala J, Herva R, Kingsmore S, Hallman M. Cord immunoproteins as predictors of respiratory outcome in preterm infants. Am J Obstet Gynecol 2009; 200: 100 e1-8.
18. Woldesenbet M, Rosenfeld CR, Ramilo O, Johnson-Welch S, Perlman JM. Severe neonatal hypoxic respiratory failure correlates with histological chorioamnionitis and raised concentrations of interleukin 6 (IL6), IL8 and C-reactive protein. Arch Dis Child Fetal Neonatal Ed 2008; 93: F413-F417.
19. Been JV, Zimmermann LJ. Histological chorioamnionitis and respiratory outcome in preterm infants. Arch Dis Child Fetal Neonatal Ed 2009; 94: F218-F225.
20. Lahra MM, Beeby PJ, Jeffery HE. Maternal versus fetal inflammation and respiratory distress syndrome: a 10-year hospital cohort study. Arch Dis Child Fetal Neonatal Ed 2009; 94: F13-F16.
21. Lahra MM, Jeffery HE. A fetal response to chorioamnionitis is associated with early survival after preterm birth. Am J Obstet Gynecol 2004; 190: 147-151. (Pubitemid 38156339)
22. Thebaud B, Abman SH. Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med 2007; 175: 978-985. (Pubitemid 46741748)
23. Kramer BW, Kaemmerer U, Kapp M, Herbst D, Marx A, Berg D et al. Decreased expression of angiogenic factors in placentas with chorioamnionitis after preterm birth. Pediatr Res 2005; 58: 607-612. (Pubitemid 41254532)
24. Been JV, Zimmermann LJ, Debeer A, Kloosterboer N, van Iwaarden JF. Bronchoalveolar lavage fluid from preterm infants with chorioamnionitis inhibits alveolar epithelial repair. Respir Res 2009; 10: 116.
25. Heremans H, Dillen C, Groenen M, Matthys P, Billiau A. Role of interferon-gamma and nitric oxide in pulmonary edema and death induced by lipopolysaccharide. Am J Respir Crit Care Med 2000; 161: 110-117. (Pubitemid 30055911)
26. Torrance HL, Voorbij HA, Wijnberger LD, van Bel F, Visser GH. Lung maturation in small for gestational age fetuses from pregnancies complicated by placental insufficiency or maternal hypertension. Early Hum Dev 2008; 84: 465-469.
27. Jobe AH. Antenatal factors and the development of bronchopulmonary dysplasia. Semin Neonatol 2003; 8: 9-17. (Pubitemid 36356489)
28. Bose CL, Dammann CE, Laughon MM. Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch Dis Child Fetal Neonatal Ed 2008; 93: F455-F461.
29. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, Maniscalco WM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 164: 1971-1980. (Pubitemid 33152338)
30. Ambalavanan N, Carlo WA. Bronchopulmonary dysplasia: new insights. Clin Perinatol 2004; 31: 613-628. (Pubitemid 39119488)